Covid-19 across the world: The Thai authorities have adopted new guidelines to declare Covid-19 an endemic in the Thailand, while Denmark is all set to ease curbs now. Here’s everything happening across the globe.
FRESH GUIDELINES IN THAILAND
Thai health authorities approved fresh guidelines outlining the parameters for declaring the coronavirus pandemic an endemic disease. Official figures lookout that the country already meets the three criteria, but Ministry of Public Health spokesman Rungrueng Kitphati told, it would still be between 6 months and a year before the government would be able to make the decision to start treating Coronavirus as an illness that is here to stay, like the measles or flu.
The guidelines drawn up by the ministry’s National Communicable Disease Committee are made up of 3 criteria: that there are fewer than 10,000 new average cases per day; that the fatality rate is no higher than 0.1 % (per-cent) of those who are admitted to the hospital with an infection; and that more than 80% ‘per-cent’ of at-risk people have had at least 2 (two) vaccinations.
DENMARK TO EASE CURBS
The Danish government has come up to ease the current Danish travel restrictions which would be effective from February 1, 2022. The list of approved Coronavirus vaccines recognized for entry into Denmark will be expanded as well. These vaccines include Covaxin, Covishield, Sinopharm, and Sinovac.
Moreover, the country-based approach towards fully-vaccinated travellers from 3rd countries will also be lifted. This means, there is no travel restrictions will applicable to travellers who, are in possession of a valid vaccination, regardless of their country of residence, or recovery certificate. However, Travel restrictions will, still apply to travellers who have not been previously infected or who are not vaccinated with an approved vaccine.
BRITAIN – START ROLLING OUT PFIZER COVID PILL NEXT MONTH
Britain will start rolling out Pfizer’s coronavirus pill to vulnerable people next month, the health ministry told on Friday, targeting the treatment at people with compromised immune systems for whom the vaccine may be less effective.
The health ministry also told that Pfizer’s antiviral treatment Paxlovid, a combination of Pfizer’s pill with an older antiviral ritonavir, will be made available to thousands of people from February 10, 2022.